Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage - Wikidata - wikimedia - TriplyDB

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

http://www.wikidata.org/entity/Q28268161

about

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.Non-linear significant relationship between use of glycopeptides and isolation of vancomycin-resistant Enterococcus species in a university hospital setting.A Qualitative Analysis of Implementation of Antimicrobial Stewardship at 3 Academic Hospitals: Understanding the Key Influences on Success.Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains.Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.Enterococcus faecalis infective endocarditis: focus on clinical aspects.The prevention and management of infections due to multidrug resistant organisms in haematology patients Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.Structure and Dimerization of IreB, a Negative Regulator of Cephalosporin Resistance in Enterococcus faecalis.Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy.[Antibiotic stewardship: Measures for optimization of antibacterial therapy].The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study.Factors influencing ceftriaxone use in community-acquired pneumonia: Emergency doctors' perspectives.Vancomycin-resistant enterococci infection: not just for the transplanted.Patterns of outpatient ceftriaxone use in a Japanese general hospital: an increased need for development of outpatient parenteral antimicrobial therapy programs.Surveillance of Antibiotic Use and Resistance in Intensive Care Units (SARI).Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.

P2860

Q33880518-B63C02E3-420C-4F6D-B10F-AC6FB3CC0A2A Q34257898-99E86377-7B01-48CD-B64B-6AC533308FE8 Q35080067-14E49F27-22FD-44BE-AF8D-C2E227F46927 Q35740564-E75FD54C-CAE5-422F-A055-1FEDB11D3E17 Q36161210-B0F7F67A-2137-4358-86E7-2FFE8E47C52C Q36274141-46B64A6F-2075-4701-8A2F-5E654ADEABE7 Q36887732-66BAF8CA-8277-4C40-AACD-D6389E1AE5DA Q37105688-DFDC2EC5-D002-4AC1-901B-CF344BF1E75C Q37648626-0061C782-B820-40A2-8007-33049EBB72E8 Q38145269-A285C207-E564-4DD2-960E-C9CA88FB02B5 Q38171538-1C202808-772A-4C3F-8BF8-E45E25C89501 Q39130315-5ECAAD0D-B883-49D6-9F50-6EFF782CD21B Q40196576-A28B60FC-F061-4287-A92D-55CD3B46D305 Q40694966-77BE8F48-A915-4BF6-9AFC-326FED485732 Q40945701-EFD27FA2-5DFD-4BDB-8579-B2385A384377 Q41107919-3F4E0871-4DA7-447F-B66E-A4B95E828757 Q41670471-8D7C6A07-06F2-4A65-8FBA-16FF67B3BCDC Q42248187-7AF1D78F-7FDD-4771-9D0C-3149FB5E50AB Q43464031-23E953F2-3344-4847-99AD-5B3CC8DDF96B Q47260571-31E9E41D-FAE9-41FD-86B6-B7711C532010 Q49446863-234E23C7-BA4A-4A76-8A2C-68EAFCF36A67

P2860

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

http://www.wikidata.org/entity/Q28268161

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@ast

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@en

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@nl

type

label

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@ast

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@en

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@nl

prefLabel

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@ast

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@en

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@nl

P1433

Q28268161-D6D998E8-0A93-4B67-AF53-3309CD01257A

P1476

Q28268161-DDB56D8B-46E1-4E8A-8CA1-A785629B0EB9

P2093

Q28268161-2AE1743F-A4BE-4D96-84F2-E7F3201F644B

Q28268161-2FB108AD-DDDF-4278-8966-143357A08912

Q28268161-488C26AB-3CC3-4083-BC87-6CB9F3F39161

Q28268161-50E016BE-21D4-49F0-A16A-54DB81B51206

Q28268161-53207CC0-1836-4E8E-92BC-43B1CCA67B80

Q28268161-661C7807-F8F8-4EA8-AF95-48B75EDB38E7

Q28268161-C8FAEB6A-3B53-462F-9911-75243C6CB596

Q28268161-D1ADCCC4-0690-4039-AA9B-12E6225AC87F

Q28268161-E8D72C78-3D25-43FE-9E39-899AF823A9C8

P2860

Q28268161-06E31A39-D10F-40F9-A657-CB2D6B526420

Q28268161-08CDBE3F-278E-424E-9DD9-A7946314139F

Q28268161-1AA2C9F3-6BF2-4DA2-8D5A-FD3719596A08

Q28268161-1CB53050-6FEC-45A8-A962-1C720CFEFF4B

Q28268161-1E92A494-3E75-420A-8244-6660DF0E0F24

Q28268161-1F3E3693-6730-4AEE-BCE2-28DE2B6C82C7

Q28268161-2E366586-9922-45D3-90EA-43CC699093AC

Q28268161-31BC693D-C580-424B-91D5-B02FEDC3B872

Q28268161-348D8C45-451B-406E-8C72-D1EA6C6CD750

Q28268161-35446438-88A8-43F4-A068-3824FDBF1BFF

P304

Q28268161-C7EFC8E0-C024-496A-AB04-35101119BB0C

P31

Q28268161-FD4C5981-F508-4C0D-A211-345D60DC5C47

P356

Q28268161-843BB532-5141-42A9-B5DA-34A7927A4562

P407

Q28268161-DEDAA5C5-49A2-4DF3-BE7B-CCD181770A7C

P433

Q28268161-C527D358-F7F4-435A-9226-194DF5CF239A

P478

Q28268161-FCFE3BA8-5FF6-4058-83C2-A64DA32D6700

P577

Q28268161-D9CD4518-AA4F-451D-9D58-0FE0B73D509A

P5875

Q28268161-0EAFAF59-CBE3-48F6-8EBC-71A687627DDD

P698

Q28268161-787687DD-D26C-42C8-A462-73A9D93E2677

P921

Q28268161-376EB175-71B8-4784-86FE-71B3A147E475

P932

Q28268161-47B35D7B-149A-4C39-BFC8-5ECB6FD67625

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

@en

P2093

Danielle F Kunz

http://www.w3.org/2001/XMLSchema#string

Eric Chamot

http://www.w3.org/2001/XMLSchema#string

James A McKinnell

http://www.w3.org/2001/XMLSchema#string

John W Baddley

http://www.w3.org/2001/XMLSchema#string

Loren G Miller

http://www.w3.org/2001/XMLSchema#string

Mukesh Patel

http://www.w3.org/2001/XMLSchema#string

Peter G Pappas

http://www.w3.org/2001/XMLSchema#string

Rhett M Shirley

http://www.w3.org/2001/XMLSchema#string

Stephen A Moser

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating health care-associated infections and deaths in U.S. hospitals, 2002

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.

Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review

The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital.

Decreased antimicrobial resistance after changes in antibiotic use.

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.

P304

718-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/666331

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225272667

http://www.w3.org/2001/XMLSchema#string

P698

22669234

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

3879097

http://www.w3.org/2001/XMLSchema#string